Regional markets in the Asia Pacific are witnessing a significant growth in the sterility testing market, emerging as the fastest-growing market globally. In particular, parenteral products, which are administered through injection or infusion, undergo rigorous sterility testing to ensure they are free from pyrogens. Sterility testing is a critical process in this industry as it is conducted to detect the presence of pyrogenic compounds or any foreign materials that can impact the quality and safety of the final product. The pharmaceutical and biotechnology segment has emerged as the leader in the sterility testing market, holding the largest market share. Pharmaceutical and Biotechnology Segment is Expected to Grow in the Market Due to the Increasing Demand for Sterility Testing Services The presence of leading biopharmaceutical and biotechnology companies in the region and ongoing research and development efforts focused on finding cures for chronic diseases have contributed to the market's growth. The markets in North America have emerged as the dominant region in the global sterility testing market. Prominent Players in Sterility Testing MarketĬharles River Laboratories International, Inc. In pharmaceutical practice, a container is deemed sterile when the probability of being contaminated with replicating microorganisms is less than one out of one million in sterility testing market. Sterility is a crucial concept in the pharmaceutical industry and refers to the absence of viable microorganisms. Furthermore, as safety concerns related to biological medicinal products continue to increase, there is a growing emphasis on ensuring the sterility and quality of these products.īrowse in-depth TOC on "Sterility Testing Market" The flourishing biotechnology industry worldwide is another factor that will contribute to expanding the market during the forecast period. Westford, USA, J(GLOBE NEWSWIRE) - According to SkyQuest, the demand for sterility testing market is expected to experience a significant growth with continuous advancements in the pharmaceutical and medical fields. This investment aimed to provide additional capacity for manufacturing single-use bioprocess container (BPC) systems, crucial for sterile liquid-handling applications in the biopharmaceutical industry. One such example is the announcement recently made by Thermo Fisher Scientific Inc., where they planned to invest more than US$ 50 million in expanding their global bioproduction capabilities. The sterility testing market is anticipated to grow substantially owing to the increasing investments and funding. SkyQuest projects that the sterility testing market will attain a value of USD 469 million by 2030, with a CAGR of 12.6% over the forecast period (2023-2030).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |